Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01X OTHER ANTINEOPLASTIC AGENTS
       L01XA Platinum compounds
       L01XB Methylhydrazines
       L01XC Monoclonal antibodies
       L01XD Sensitizers used in photodynamic/radiation therapy
       L01XE Protein kinase inhibitors
         L01XE01 Imatinib [DG:DG00710]
         L01XE02 Gefitinib
         L01XE03 Erlotinib [DG:DG00711]
         L01XE04 Sunitinib [DG:DG00712]
         L01XE05 Sorafenib [DG:DG00713]
         L01XE06 Dasatinib [DG:DG00714]
         L01XE07 Lapatinib [DG:DG00715]
         L01XE08 Nilotinib [DG:DG00716]
         L01XE09 Temsirolimus
         L01XE10 Everolimus
         L01XE11 Pazopanib
         L01XE12 Vandetanib
         L01XE13 Afatinib [DG:DG00717]
         L01XE14 Bosutinib [DG:DG00718]
         L01XE15 Vemurafenib
         L01XE16 Crizotinib
         L01XE17 Axitinib
         L01XE18 Ruxolitinib [DG:DG00719]
         L01XE19 Ridaforolimus
         L01XE21 Regorafenib [DG:DG00720]
         L01XE22 Masitinib
         L01XE23 Dabrafenib [DG:DG00721]
         L01XE24 Ponatinib [DG:DG00722]
           D09950  Ponatinib (USAN/INN)
           D09951  Ponatinib hydrochloride (JAN/USAN)
         L01XE25 Trametinib [DG:DG00723]
         L01XE26 Cabozantinib [DG:DG01670]
         L01XE27 Ibrutinib
         L01XE28 Ceritinib
         L01XE29 Lenvatinib [DG:DG01362]
         L01XE31 Nintedanib [DG:DG01374]
         L01XE32 Cediranib [DG:DG01360]
         L01XE33 Palbociclib [DG:DG01831]
         L01XE34 Tivozanib [DG:DG01375]
       L01XX Other antineoplastic agents
       L01XY Combinations of antineoplastic agents
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: June 21, 2016
According to WHO's ATC 2016

» Japanese version